scholarly journals Short and long-term experiments on the effect of sulphide on microalgae cultivation in tertiary sewage treatment

2017 ◽  
Vol 244 ◽  
pp. 15-22 ◽  
Author(s):  
J. González-Camejo ◽  
R. Serna-García ◽  
A. Viruela ◽  
M. Pachés ◽  
F. Durán ◽  
...  
1975 ◽  
Vol 34 (02) ◽  
pp. 445-545 ◽  
Author(s):  
Michael Weintraub ◽  
Paul F Griner

SummaryThe interaction between warfarin and the new lipid lowering agent halofenate (MK 185) [2 - acetamidoethyl (p-chlorophenyl) (m-trifluoromethylphenoxy) acetate] was studied in dogs in both short- and long-term experiments. Our data suggest that halofenate potentiates the anticoagulant effect of warfarin by increasing the degradation of prothrombin (factor II) (Kdeg on placebo = 211 ± 32 × 10−4 × Hr−1 mean ± SEM; on halofenate = 268 ± 39 × 10−4 × Hr−1 mean ± SEM; P < 0.01). However, a concomitant increase in factor II synthesis of 34% results in resistance to warfarin’s effect if halofenate is administered prior to warfarin. The mean prothrombin time of 4 dogs on 2 mg of warfarin following halofenate pretreatment for 8 weeks was 74.8% ± 17.3 (SE) of the anticoagulated control dog. On 2 mg of warfarin alone, it was 133.7% ± 42.0 (P < 0.001). Cessation of halofenate from combined therapy results in a delayed augmentation of warfarin effect. These data suggest that the nature of the interaction between warfarin and drugs such as halofenate which alter the kinetics of prothrombin may depend on the sequence of administration.


2010 ◽  
Vol 119 (1) ◽  
pp. 20-26 ◽  
Author(s):  
Adriana Pereira Silva ◽  
Letícia Carlos Babujia ◽  
Julio Cezar Franchini ◽  
Rosinei Aparecida Souza ◽  
Mariangela Hungria

2011 ◽  
Vol 2011 (1) ◽  
pp. 1080-1089 ◽  
Author(s):  
Pongsak Noophan ◽  
Peerapas Narinkongnong ◽  
Chalermraj Wantawin ◽  
Junko Munakata-Marr

Swiss Surgery ◽  
2001 ◽  
Vol 7 (1) ◽  
pp. 20-24 ◽  
Author(s):  
Robert ◽  
Mariéthoz ◽  
Pache ◽  
Bertin ◽  
Caulfield ◽  
...  

Objective: Approximately one out of five patients with Graves' disease (GD) undergoes a thyroidectomy after a mean period of 18 months of medical treatment. This retrospective and non-randomized study from a teaching hospital compares short- and long-term results of total (TT) and subtotal thyroidectomies (ST) for this disease. Methods: From 1987 to 1997, 94 patients were operated for GD. Thirty-three patients underwent a TT (mostly since 1993) and 61 a ST (keeping 4 to 8 grams of thyroid tissue - mean 6 g). All patients had received propylthiouracil and/or neo-mercazole and were in a euthyroid state at the time of surgery; they also took potassium iodide (lugol) for ten days before surgery. Results: There were no deaths. Transient hypocalcemia (< 3 months) occurred in 32 patients (15 TT and 17 ST) and persistent hypocalcemia in 8 having had TT. Two patients developed transient recurrent laryngeal nerve palsy after ST (< 3 months). After a median follow-up period of seven years (1-15) with five patients lost to follow-up, 41 patients having had a ST are in a hypothyroid state (73%), thirteen are euthyroid (23%), and two suffered recurrent hyperthyroidism, requiring completion of thyroidectomy. All 33 patients having had TT - with follow-ups averaging two years (0.5-8) - are receiving thyroxin substitution. Conclusions: There were no instances of persistent recurrent laryngeal nerve palsy in either group, but persistent hypoparathyroidism occurred more frequently after TT. Long after ST, hypothyroidism developed in nearly three of four cases, whereas euthyroidy was maintained in only one-fourth; recurrent hyperthyroidy was rare.


Author(s):  
Ian Neath ◽  
Jean Saint-Aubin ◽  
Tamra J. Bireta ◽  
Andrew J. Gabel ◽  
Chelsea G. Hudson ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document